# S-Nitrosylation Therapy of COVID-19

> **NCT04528771** · EARLY_PHASE1 · WITHDRAWN · sponsor: **James Reynolds**

## Conditions studied

- SARS-CoV2 Infection
- Covid19

## Interventions

- **DRUG:** SNO
- **DRUG:** Nitrogen gas

## Key facts

- **NCT ID:** NCT04528771
- **Lead sponsor:** James Reynolds
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2021-08-05
- **Primary completion:** 2025-03-31
- **Final completion:** 2025-04-30
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Study delays
- **Last updated:** 2025-05-07

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04528771

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04528771, "S-Nitrosylation Therapy of COVID-19". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT04528771. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*